Yazheng Stomatology Completes IPO Counseling Filing for A-share Listing, Huger Stomatology Submits Application to Hong Kong Exchanges and Clearing Limited for the Third Time, Denfac Officially Launches Alberry Brand, WHO Releases First Guideline on Dental Caries Prevention and Management...

Dentfac's ALBERRY Brand Officially Launched, Four Global Precision Manufacturing Giants Renew Contracts on the Same Day to Safeguard Product Quality

*Digital Dental Restoration Clinical Academic Forum & ALBERRY Digital Solution Launch Ceremony*

Dentfac Medical Device (Wuxi) Co., Ltd. launched the ALBERRY digital solution during the 31st South China International Stomatological Exhibition. Concurrently, brand authorization ceremonies were completed for 20 dental laboratories, and contracts were renewed with four global leading precision machining suppliers: Switzerland's ROLLOMATIC, Switzerland's KKS, Germany's Zapp, and Switzerland's WILLEMIN-MACODEL. Dentfac stated that this marks the first time in China's dental industry that four suppliers have renewed contracts simultaneously.

At the launch event, ALBERRY introduced a warranty card for its Custom Abutment crown and bridge products. The products are insured with a product quality liability insurance policy from PICC Property and Casualty Company Limited (PICC), equipped with a Unique Device Identifier (UDI), included in the medical insurance code database, and support full-process traceability.

During the academic forum, experts engaged in in-depth discussions on personalized restoration materials and techniques, Subperiosteal Implant R&D, and personalized implant aesthetic restoration. It is reported that ALBERRY focuses on personalized Dental Implant abutments and bridges, achieving technical assurance through micron-level machining precision and high-performance materials.

Sinocera Plans to Acquire Australian Dental Consumables Maker SDI at 58% Premium

Shandong Sinocera Functional Material Co., Ltd. announced its intention to acquire all shares of the Australian listed company SDI Limited at a 58% premium, with a total transaction value of approximately 816 million RMB. According to the signed agreement, the acquisition price is set at A$1.40 per share, representing a 58% premium over SDI's closing price of A$0.885 on that day. SDI primarily manufactures oral Consumables such as composite resins, amalgams, and their alternative materials. It has production facilities in Victoria, Australia, and its products are sold in over 100 countries and regions worldwide. The transaction is subject to various regulatory approvals and is expected to be implemented in late May to early June 2026.

Zhengya Stomatology Completes A-share IPO Tutoring Filing

On February 25, 2026, Zhejiang Zhengya Stomatology Co., Ltd. completed its A-share IPO tutoring filing, signing a tutoring agreement with China Securities Co., Ltd. The company, founded in 2010 with a registered capital of 360 million RMB, primarily focuses on Clear Aligner products and has served approximately 1.5 million patients. The tutoring plan is divided into three stages, with a summary report expected to be submitted in June 2026. The board completed personnel adjustments before the filing, with controlling shareholder Yao Junfeng holding a 39.57% stake. Zhengya Stomatology's first round of tutoring, initiated in May 2023, has been terminated; the sponsors were China International Capital Corporation Limited and Sealand Securities.

Huge Dental Submits Listing Application to HKEX for the Third Time

On February 27, 2026, Huge Dental's holding company, Huge Dental Limited, submitted its third application for a main board listing to Hong Kong Exchanges and Clearing Limited (HKEX). The joint sponsors are China International Capital Corporation (Hong Kong) Limited and DBS Asia Capital Ltd. The prospectus shows that from 2023 to 2025, Huge Dental's revenues were 358 million RMB, 399 million RMB, and 400 million RMB respectively, while net profit dropped from 88.354 million RMB to 47.699 million RMB, a cumulative decline of 46.0%. The company stated that the IPO proceeds will be used to upgrade production lines at its Rizhao factory, establish a factory in Indonesia, and invest in digital technology R&D, among other projects.

South China Exhibition Observation Collection:

South China Exhibition Observation | Chengliang Technology's cooperation rate with domestic dental laboratories reaches 70%, plans to establish processing centers in North America, Europe, etc.

South China Exhibition Observation | Zhilineng Technology's new edentulous implant restoration product shortens precise scanning process to fifteen minutes.

South China Exhibition Observation | Shanghai Yangshan Medical Technology Co., Ltd.'s new Dental Surgical Robot may solve the problem of limited field of view in traditional surgery.

South China Exhibition Observation | Aoshimei launches a follow-up reading system covering the entire process from case diagnosis to follow-up monitoring.

South China Exhibition Observation | Dikaier launches new oral implant equipment and teaching products.

South China Exhibition Observation | Youfang Medical claims sales growth against the trend, ranking first in product installation growth.

South China Exhibition Observation | Gelen Technology collaborates with South China Exhibition to create the "Medviewer Future Clinic" experience zone.

South China Exhibition Observation | Xunshi Technology states its new 3D printer completes the printing process in 40 minutes, plans to strengthen promotion of AI design technology.

South China Exhibition Observation | Shining 3D launches a 106-gram lightweight Intraoral Scanner (IOS).

… …

Arrail Group: Independent Investigation Delayed, Interim Results Release Postponed to End of April

On March 2, 2026, Arrail Group issued an announcement stating that due to the independent investigation not being completed as scheduled, the release date for the interim results for the period ended September 30, 2025, has been postponed from the expected end of February 2026 to the end of April 2026. Main reasons include loss of internal documents, limited time for employee interviews, and delays in external responses. The company's shares have been suspended from trading since December 1, 2025. Independent forensic accountant EY has completed the retrieval of relevant bank statements and transaction records and is conducting follow-up interviews. Grant Thornton was appointed as the new auditor on February 14, 2026, and has begun reviewing the interim financial statements. Arrail Group stated that aside from the independent investigation, the group's business operations are normal, and it expects a pre-tax profit of no less than 20 million RMB for the first half of the 2026 fiscal year.

Insurance Group Principal Acquires Alabama's Largest Dental Network, DentaNet

On March 3, 2026, Principal Financial Group (Nasdaq: PFG) and Southland Benefit Solutions (SBS) signed a definitive agreement for Principal to acquire Alabama's largest dental network, DentaNet, and obtain renewal rights for certain group insurance contracts of its subsidiary, Canopy Insurance. DentaNet currently has approximately 1,500 dental service providers and will become the fourth member of Principal's proprietary network post-acquisition. As of December 31, 2025, Principal provides dental insurance plans to over 60,000 businesses, covering nearly 2.8 million enrollees. Financial terms of the transaction were not disclosed.

Q & M Dental Group 2025 Annual Report: Revenue Up 9%, Net Profit Attributable to Shareholders of the Parent Company Down 35%

Q & M Dental Group released its 2025 performance report. Revenue reached 197.2 million SGD, a year-on-year increase of 9.16%; Net Profit Attributable to Shareholders of the Parent Company was 9.312 million SGD, a year-on-year decrease of 34.71%. Core dental business net profit grew by 16.47% to 30.426 million SGD. The profit decline was mainly due to the impact of one-time losses and interest expenses on medium-term notes. Group revenue in Singapore, Malaysia, and China was 167 million SGD, 12.712 million SGD, and 17.924 million SGD, respectively. The group plans to enter the Chinese market by consolidating Aoxin Q & M Dental and issued 130 million SGD in medium-term notes in July 2025 with a coupon rate of 3.95%. As of the end of 2025, the group operates 110 dental clinics in Singapore.

UK Competition and Markets Authority Officially Launches Market Study into Private Dentistry, Initial Consultation Prices Rise Over 23% in 2 Years

On March 5, 2026, the UK Competition and Markets Authority (CMA) officially launched a market study into the UK private dentistry market. This follows private initial consultation fees rising over 23% to £80 (approximately 735.84 RMB) between 2022 and 2024, and follow-up consultation fees rising over 14% to £55 (approximately 505.89 RMB). Private services account for about 69% of the overall dental market, valued at £8.4 billion (approximately 772.63 billion RMB). The CMA will focus on aspects such as service accessibility, price transparency, and business conduct. The study's conclusions may lead to regulatory reforms or enforcement actions.

'Ordinary Course of Business' Exception, Court Dismisses Lawsuit Against Dental DSO Involving AI Call Recording

The U.S. District Court for the Northern District of Illinois dismissed the lawsuit filed by Megan Lisota against Heartland Dental and RingCentral, based on the "ordinary course of business" exception under the Electronic Communications Privacy Act (ECPA). Lisota alleged her calls were transcribed and analyzed by AI without notification and consent. The court determined that RingCentral's AI functionality was a core service, thus not constituting unlawful interception. Heartland Dental, merely procuring the related services, also bore no ECPA liability. This case is among the first federal rulings involving a Dental Service Organization (DSO) using AI call analysis tools. As of press time, the plaintiff has not announced next steps.

U.S. Federal Court Issues First Ruling on Dental DSO AI Call Recording Case

The U.S. District Court for the Northern District of Illinois procedurally dismissed the lawsuit filed by plaintiff Lisota against Heartland Dental and RingCentral on grounds of "failure to state a claim." The plaintiff alleged that Heartland Dental used AI tools to record calls without patient consent, violating the "two-party consent" provision of the Federal Wiretap Act. Heartland Dental is the largest Dental Service Organization (DSO) in the U.S., supporting over 1,800 affiliated clinics. The court found the plaintiff failed to clearly define the legal roles of Heartland Dental and RingCentral in call processing and did not specify the content of the recorded calls. The plaintiff may amend the complaint and refile. California and Texas have enacted legislation requiring healthcare providers to provide written disclosure when using AI to communicate with patients.

Planet DDS Launches Dental AI Agents, Targeting DSO Appointment Management

U.S. dental software provider Planet DDS released the DentalOS™ AI Agent, introducing the first two AI automation agents embedded in front-office workflows. Early access applications are open to users of its Denticon and Cloud 9 platforms. The first agents target appointment management. The Appointment Confirmation Agent can increase confirmation rates by 20% to 50%, reduce no-show rates by 15% to 30%, and save front-office staff 60% to 75% of manual confirmation time. Planet DDS disclosed that the average no-show rate for dental practices is 15%, with each practice losing over $150,000 (approximately 1.09 million RMB) annually. New agent roles covering clinical coordination, patient communication, and revenue cycle management are expected to launch in 2026.

WHO Releases First Global Guideline on Caries Prevention and Management, 8 Recommendations Advocate Mercury-Free Materials as Amalgam Alternatives

On March 3, 2026, the World Health Organization (WHO) released its first global guideline, Environmentally Sustainable and Minimally Invasive Oral Health Care for Caries Prevention and Management, providing 8 evidence-based recommendations and 2 best practice statements covering the complete clinical pathway from caries prevention to restoration. The 8 recommendations include fluoride varnish, silver diamine fluoride, fluoride toothpaste, glass ionomer cement sealants, atraumatic restorative treatment, preventive resin restoration, minimally invasive caries removal techniques, and mercury-free restorative materials. The guideline recommends resin-based composites and glass ionomer cements as alternatives to dental amalgam and notes that materials containing bisphenol A (BPA) have usage limitations for pregnant women and children under 8 years old. WHO plans to host a global launch webinar on March 19, 2026, to formally introduce the guideline.

New Research: PTA-PHMG Coating Achieves Simultaneous Antibacterial and Immune Regulation, May Provide New Design Pathway for Oral Mucosa Repair Materials

A research team from Beijing Stomatological Hospital, Capital Medical University, and Beijing University of Chemical Technology published a study on PTA-PHMG coating in the journal Advanced Functional Materials, proposing a new design pathway for oral mucosa repair materials. In animal experiments, this coating achieved stable adhesion, broad-spectrum antibacterial properties, and macrophage immune regulation. It successfully reduced the expression of pro-inflammatory cytokine mRNA (such as Tnf, Il6) and promoted macrophage transformation towards the anti-inflammatory (M2) type. The study indicated this is related to the activation of signaling pathways like PI3K/Akt. The research is currently still in the animal experiment stage, and the clinical translation pathway requires further study.